Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sanofi Poaches New CMO from Novartis AG

March 10, 2016By Mark Terry, Breaking News Staff   Paris-based Sanofi (SNY) announced today that Ameet Nathwani has been appointed as executive vice president, group chief medical officer. This position was previously held by Paul Chew under the title senior vice president, chief medical officer. Chew plans to retire later this year. As part […]

Read More »

Bacterial infection in Wisconsin may have killed 18; CDC investigating

A blood infection known as Elizabethkingia has been linked to 18 deaths in Wisconsin and local health officials and the U.S. Centers for Disease Control and Prevention are investigating the source, officials said on Wednesday. The infection has been found in 48 people between Nov. 1, 2015 and March 9, according to the Wisconsin Department […]

Read More »

First U.S. uterus transplant fails due to complications – Ohio hospital

The first uterus transplant in the United States has failed and the Ohio hospital that performed the procedure said on Wednesday the organ was removed due to an unspecified complication. “We are saddened to share that our patient, Lindsey, recently experienced a sudden complication that led to the removal of her transplanted uterus,” Cleveland Clinic […]

Read More »

Sutro Expands Senior Leadership Team with Addition of Chief Medical Officer and VP of Translational Pharmacology and Preclinical Development

SAN FRANCISCO, March 9, 2016 /PRNewswire/ — Sutro Biopharma today announced the appointment of Arturo Molina, M.D., M.S., FACP as chief medical officer and Mark Lupher, Ph.D., as vice president of translational pharmacology and preclinical development (TP&PD). Both Dr. Molina and Dr. Lupher bring exceptional talent and over 40 years of therapeutic program development to Sutro. […]

Read More »

CSL Behring Awards LEAD Grants to Help Rare Disease Patient Groups Achieve Their Advocacy Objectives

KING OF PRUSSIA, Pa., March 9, 2016 /PRNewswire/ — Patients are their own most important advocates, and global biotherapeutics leader CSL Behring has renewed its commitment to helping empower them with the announcement of the latest round of LEAD Grant awards. CSL Behring established the LEAD grant program in 2008 to help support the important […]

Read More »

WHO lists Zika R&D priorities, says vaccine may come too late

A meeting of experts on the Zika virus outbreak has agreed on three top priorities for research into medical products, the World Health Organization said on Wednesday, warning that vaccine trials may come too late for the current outbreak. The top priorities were tests for other viruses such as dengue and chikungunya as well as […]

Read More »

Lupin Completes its Acquisition of GAVIS

MUMBAI and BALTIMORE, March 9, 2016 /PRNewswire/ — New Jersey based GAVIS is a privately held company specializing in formulation development, manufacturing, packaging, sales, marketing, and distribution of pharmaceuticals products. GAVIS has 62 ANDA filings pending approval with the US FDA and a pipeline of over 65+ products under development. 72% of these filings pending […]

Read More »

Experts perplexed over why Sharapova was taking banned heart drug

The medicine Maria Sharapova says she has taken for 10 years due to a family history of heart issues and diabetes is an old drug sold in just a few Eastern European countries that can also boost exercise tolerance. The tennis star tested positive for the banned drug meldonium, or Mildronate, in a sample taken […]

Read More »

Israeli placental cell therapy could cure radiation sickness

Israeli biotech firm Pluristem Therapeutics said it hopes its anti-radiation therapy will protect Fukushima workers decommissioning nuclear reactors and save lives in the future if ever a similar catastrophe occurs. The Haifa-based company said they have developed a placenta-based cell therapy injection that can fully cure patients with multiple organ failure caused by high radiation […]

Read More »

Women lag men as lead authors in top medical journals

(Reuters Health) — Women are more apt to be lead authors of research in major medical journals today than they were a generation ago, but they still lag significantly behind men, a recent study suggests. The gender gap matters because lead authors make key decisions on what topics to research, who to include in studies, […]

Read More »

McCann Health Promotes Charlie Buckwell to President, EMEA

Michel Nakache also promoted by McCann Health to Head of Global Clients Unit

Read More »

Chipotle’s shares drop after latest food safety incident

Shares of Chipotle Mexican Grill Inc fell almost 6 percent in morning trading on Wednesday, a day after the popular burrito chain operator said it would temporarily shut a Massachusetts restaurant after four employees fell sick. Chipotle is trying to repair its reputation after a series of food-safety incidents, including two E. coli outbreaks that […]

Read More »

Roche receives CFDA approval for CINtec PLUS Cytology test

Roche receives approval in China for the CINtec PLUS Cytology test …

Read More »

Bristol-Myers Squibb says stops some initiatives in China

U.S. drugmaker Bristol-Myers Squibb said on Tuesday it had stopped “certain initiatives” in China …

Read More »

Sanofi and Merck pull the plug on European vaccines venture

Sanofi SA and Merck & Co. Inc. announced that they are ending a 22-year-old joint venture to sell vaccines in Europe …

Read More »

Gilead, Merck & Co. Duke It Out Over Hep C $1,000-Pill Royalties

March 8, 2016 By Alex Keown, Breaking News Staff   FOSTER CITY, Calif. – Gilead Sciences (GILD) could owe Merck (MRK) more than $3 billion in a patent dispute over its block buster hepatitis C treatment if a jury finds Merck’s own hepatitis C patents are still viable, Bloomberg reported this morning. Merck challenged […]

Read More »

U.S. industry body says India agreed to not issue ‘compulsory’ drug licenses

India has given private assurances that it will not grant licences allowing local firms to override patents and make cheap copies of drugs by big Western drugmakers, a U.S. business advocacy group said.   The comments were revealed in a submission last month by the U.S.-India Business Council (USIBC) to the U.S. Trade Representative (USTR), […]

Read More »

People with anxiety may be hard-wired to see world differently

People with anxiety may not be able to distinguish between neutral and threatening stimuli as well as individuals without anxiety, a small study suggests. Researchers designed a sound experiment to explore the brain’s plasticity, or its ability to change and respond to new situations. These changes influence how the brain reacts to stimuli and whether […]

Read More »

Being ‘out of shape’ ups diabetes risk regardless of weight

For adolescents, low cardiorespiratory fitness and poor muscle strength increase their risk for type 2 diabetes later in life, regardless of body weight, according to a study of young men in Sweden. “Not only were both low aerobic and muscular fitness linked with a higher long-term risk of diabetes, but this was true even among […]

Read More »

Celldex discontinues late-stage study of brain cancer vaccine

Celldex Therapeutics Inc said it would discontinue a late-stage study of its brain cancer vaccine after an independent interim analysis suggested the therapy might not show a statistically significant benefit in patient survival compared with standard chemotherapy. Celldex shares more than halved to $3.76 in premarket trading on Monday. The vaccine, Rintega, belongs to an […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom